1. Home
  2. NMRA vs LNKB Comparison

NMRA vs LNKB Comparison

Compare NMRA & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • LNKB
  • Stock Information
  • Founded
  • NMRA 2019
  • LNKB 2018
  • Country
  • NMRA United States
  • LNKB United States
  • Employees
  • NMRA N/A
  • LNKB N/A
  • Industry
  • NMRA
  • LNKB
  • Sector
  • NMRA
  • LNKB
  • Exchange
  • NMRA Nasdaq
  • LNKB Nasdaq
  • Market Cap
  • NMRA 287.6M
  • LNKB 274.7M
  • IPO Year
  • NMRA 2023
  • LNKB N/A
  • Fundamental
  • Price
  • NMRA $1.15
  • LNKB $7.03
  • Analyst Decision
  • NMRA Buy
  • LNKB Buy
  • Analyst Count
  • NMRA 8
  • LNKB 2
  • Target Price
  • NMRA $10.14
  • LNKB $8.25
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • LNKB 50.5K
  • Earning Date
  • NMRA 03-03-2025
  • LNKB 04-28-2025
  • Dividend Yield
  • NMRA N/A
  • LNKB 4.30%
  • EPS Growth
  • NMRA N/A
  • LNKB N/A
  • EPS
  • NMRA N/A
  • LNKB 0.71
  • Revenue
  • NMRA N/A
  • LNKB $108,499,000.00
  • Revenue This Year
  • NMRA N/A
  • LNKB $16.30
  • Revenue Next Year
  • NMRA N/A
  • LNKB $2.91
  • P/E Ratio
  • NMRA N/A
  • LNKB $9.85
  • Revenue Growth
  • NMRA N/A
  • LNKB 255.70
  • 52 Week Low
  • NMRA $1.12
  • LNKB $5.86
  • 52 Week High
  • NMRA $17.19
  • LNKB $7.98
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 30.06
  • LNKB 45.97
  • Support Level
  • NMRA $1.12
  • LNKB $6.75
  • Resistance Level
  • NMRA $1.23
  • LNKB $7.06
  • Average True Range (ATR)
  • NMRA 0.11
  • LNKB 0.19
  • MACD
  • NMRA 0.05
  • LNKB 0.01
  • Stochastic Oscillator
  • NMRA 14.15
  • LNKB 54.26

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.

Share on Social Networks: